BusinessTechnologyTop Stories

Global Renal Biomarker Market 2025- Global Trends, Market Share, Industry Size, Growth, Opportunities, an Key Company Profiled Abbott Laboratories, Alere Inc., Siemens Healthcare, Roche Diagnostics Corporation

Global Renal Biomarker Market By Type (Functional Biomarker (Serum Creatinine, Serum Cystatin C, Urine Albumin), Up-Regulated Proteins (Neutrophil Gelatinase-Associated Lipocalin, Kidney Injury Molecule-1, Liver-type fatty acid–binding protein, Interleukin-18, β-trace protein, Asymmetric dimethylarginine), Low Molecular Weight Protein (Urine cystatin C), Enzymes (N-acetyl-glucosaminidase, Glutathione-s-transferase, Gamma-glutamyl transpeptidase, Alanine aminopeptidase, Lactate dehydrogenase)), By Diagnostic Technique (Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass Spectrometry, Others), By End User (Hospitals, Clinics, Research Center, Diagnostic Labs), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Renal Biomarker Market Analysis:

The Renal Biomarker Market accounted to USD 856.7 million in 2016 growing at a CAGR of 7.2% during the forecast to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Exclusive Sample Report: @

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Request Complete TOC Of this Report @

Renal Biomarker Market Definition:

Renal biomarkers are used in diagnosis of diseases acute or chronic kidney injuries. The renal biomarkers measures the blood and urine level, detect pre-renal, intrinsic and post renal kidney injuries.

Major Market Drivers and Restraints:

  • Increasing incidences of kidney related diseases
  • Increasing prevalence of multiple co-morbidities
  • R&D investments in field of genetics
  • Weak reimbursements
  • Stringent regulatory framework

Renal Biomarker Market Segmentation:

By type the market for renal biomarker is segmented into functional biomarker up-regulated proteins), low molecular weight protein, enzymes. The functional biomarker segment is further sub-segmented into ion serum creatinine, serum cystatin c, urine albumin and up-regulated proteins segment is sub-segmented into neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, liver-type fatty acid–binding protein, interleukin-18, β-trace protein, and asymmetric dimethylarginine. The enzymes segment is further sub-segmented into N-acetyl-glucosaminidase, glutathione-s-transferase, gamma-glutamyl transpeptidase, alanine aminopeptidase, lactate dehydrogenase.

By product type the renal biomarker market is segmented into enzyme linked immunosorbent assay, particle-enhanced turbidimetric immunoassay, colorimetric assay, chemiluminescent enzyme immunoassay, liquid chromatography-mass spectrometry, others.

On the basis of end-users the renal biomarker market is segmented into hospitals, clinics, research center and diagnostic labs.

On the basis of geography, renal biomarker market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Renal Biomarker Market Competitive Analysis:

The renal biomarker market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of renal biomarker market for global, Europe, North America, Asia Pacific and South America.

Report at an Impressive Discount! Please click Here@


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *